InVitroLogics ApS: Financial statements 2023
CVR: 34044562
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
InVitroLogics ApS (CVR 34044562) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -15,211 and a net result of DKK -15,211 compared with DKK -76,236 the year before. Equity in the 2023 report amounted to DKK -410,513.
- Gross Profit
- DKK -15,211
- Profit/Loss
- DKK -15,211
- Equity
- DKK -410,513
- Total Assets
- DKK 10,631
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -15 t. | -15 t. | -411 t. | - |
| 2022 | - | -64 t. | -76 t. | -395 t. | 0 |
| 2021 | 48 t. | 48 t. | 37 t. | -319 t. | - |
| 2020 | - | -41 t. | -41 t. | -356 t. | - |
| 2019 | - | -5 t. | -5 t. | -315 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
InVitroLogics ApS has published its annual report for 2022. Gross profit came to DKK -64,465, and the net result was DKK -76,236.
About InVitroLogics ApS
InVitroLogics ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2011. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Claus Pedersen Blicher. The company is owned by ADZUKI HOLDING ApS. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,448 and a net result of DKK -2,448 compared with DKK -1,327 the year before. Equity in the 2025 report amounted to DKK -333,763.